Landong, Abdulla A.
HRN: 02 24 74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2023
CEFTAZIDIME 1GM (VIAL)
03/22/2023
03/28/2023
IV
1gm
Q8
CAP; T/C PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes